Dr Reddy’s, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir
Dr Reddy’s Laboratories HYDERABAD: Dr Reddy’s Laboratories and Hetero are among half a dozen generic drug makers to have entered into non-exclusive, royalty-free voluntary licencing agreements with Gilead Sciences Ireland UC to manufacture and distribute the latter’s human immunodeficiency virus (HIV) drug Lenacapavir in India and 120 low- and middle-income countries (LMICs).Apart from Dr Reddy’s…
